Lyme Disease Research Database Independent reporting on all aspects of Lyme Disease

Europe

New Lyme test available in Europe

A new test that detects the Borrelia infection is now available in Europe. I hope to find out whether this novel test will become available in the US anytime soon.

SpiroFind was developed in Mellrichstadt, Germany by the European subsidiary of Boulder Diagnostics, a privately owned company in Colorado that focuses on diagnosing diseases that are not reliably diagnosed.

The SpiroFind test detects Borreliosis through each stage, from early to late or chronic manifestation. It works by measuring the immune response to the Borrelia bacteria. Europeans may now contact the clinical laboratory, which is accepting blood samples for testing.

The effectiveness of the SpiroFind test was confirmed in a clinical study at the
Radboud University Nijmegen Medical Centre in the Netherlands. Conclusions of the study have been submitted for peer-reviewed publication and presentation at a conference in Berlin, Germany in April 2013.

DNA Test in US Available
Another
new Lyme disease test, which tests DNA, became available in the US in 2010. I talked to Dr. Sin Hang Lee about this test, which is available in Milford, Connecticut. Patients and physicians interested in information on this DNA test may call George Poole, manager of Milford Medical Laboratory, at 203-876-4496.

New diagnostic tools give us hope for earlier and more effective treatment.


Comments